comparemela.com

Latest Breaking News On - Marvel biotechnology inc - Page 6 : comparemela.com

Marvel Biosciences Corp.: Marvel Biosciences Announces Second Quarter 2022 Financial Results

Calgary, Alberta (Newsfile Corp. - March 30, 2022) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel") today announced

Canada
Calgary
Alberta
Canadian
Kostenloser-wertpapierhandel
Mark-williams
Marvel-biosciences-corp
Marvel-biotechnology-inc
Alberta-newsfile-corp
Regulation-services-provider
Venture-exchange
Company-or-marvel

Marvel Biosciences Corp.: Marvel Biosciences Announces Proxy Tabulation and Shareholder Meeting Results

Calgary, Alberta (Newsfile Corp. - February 15, 2022) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased

Burlington
Newfoundland
Canada
Canadian
Jeremy-fehr
J-roderick-matheson
Neila-johnson
Harry-nijjar
Gordon-bell
Joanne-yan
Jacqueline-groot
Neil-johnson

Marvel Biosciences Corp.: Marvel Biosciences Achieves CGMP Milestone and Begins IND-Enabling Pre-Clinical Toxicology Testing of Lead Compound

Calgary, Alberta (Newsfile Corp. - December 8, 2021) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased

Japan
United-states
Hong-kong
Shenzhen
Guangdong
China
Kentucky
Calgary
Alberta
Canada
America
Canadian

Marvel Biosciences Corp.: Marvel Biosciences Lead Asset MB-204 Show 47% Reduction in Liver Fibrosis and Active Indications in Multiple Pre-Clinical Models of Nash

Calgary, Alberta (Newsfile Corp. - November 23, 2021) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), today

Japan
Canada
Calgary
Alberta
Canadian
Kostenloser-wertpapierhandel
Brucen-cronstein
Mark-williams
Marvel-biosciences-corp
Marvel-biotechnology-inc
Alberta-newsfile-corp
Venture-exchange

Marvel Biosciences Corp.: Marvel Biosciences Announces New Program to Develop Novel Orally Dosed Non-Hallucinogenic Neuroplastic Promoting Compounds

Calgary, Alberta (Newsfile Corp. - October 27, 2021) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased

Canada
Calgary
Alberta
Canadian
Kostenloser-wertpapierhandel
Mark-williams
Marvel-biosciences-corp
Marvel-biotechnology-inc
Alberta-newsfile-corp
Regulation-services-provider
Venture-exchange
Company-or-marvel

vimarsana © 2020. All Rights Reserved.